
Sign up to save your podcasts
Or


Recorded live at the ADA Conference in Orlando, Florida.
Nancy Hanna is joined by Dr. Pablo Mora who is an Endocrinologist at the North Texas Diabetes & Endocrinology Medical Center in Plano, Texas. During this episode, Nancy and Dr. Mora discuss the integration between the Omnipod 5 Automated Insulin Delivery System and the Dexcom G7 CGM.
Dr. Mora discusses his experience as part of the Limited Market Release for Omnipod 5 with Dexcom G7 and provides insights into the benefit of this integration for his patients with type 1 diabetes.
Listen to learn how Dr. Mora has leveraged this technology to simplify diabetes management with his patients!
------------
Dr. Pablo Mora is an endocrinologist. Dr. Mora has an ongoing commercial relationship with Insulet and Insulet has paid him a fee to participate in this podcast. The opinions and views expressed in this podcast are his own.
Recorded live at the ADA Conference in Orlando, Florida 2024.
Nancy Hanna is joined by Cari Berget MPH, RN, CDCES who is a Research Instructor of Pediatric Endocrinology at the University of Colorado School of Medicine – Barbara Davis Center. During this episode, Nancy and Cari discuss automated insulin delivery (AID) candidacy and challenge the perception that people need to meet certain requirements to be considered for AID.
Cari shares her experience prescribing diabetes technology to patients who typically might not been considered for automated insulin delivery and shows the progress and clinical benefits that some of her patients have experienced on Omnipod 5.
------------
Cari Berget, MPH is a Registered Nurse (RN) and a Certified Diabetes Care and Education Specialist (CDCES). Cari Berget has an ongoing commercial relationship with Insulet and Insulet has paid her a fee to participate in this podcast. The opinions and views expressed in this podcast are her own.
Recorded live at the ADA Conference in Orlando, Florida.
Nancy Hanna is joined by Dr. Greg Forlenza who is an Endocrinologist at the University of Colorado School of Medicine – Barbara Davis Center. Dr. Forlenza is the lead author of a publication in the Diabetes Technology & Therapeutics in which the use of the Omnipod 5 Automated Insulin Delivery System was analyzed in almost 70,000 people with type 1 diabetes.
Nancy and Dr. Forlenza discuss the relevance of real-world evidence from a diverse group of patients and how that translates into actual practice. Learn how Omnipod 5 has performed in real-world settings, and why having this data can help personalize diabetes care by understanding how different patient demographics can benefit from tubeless AID technology.
------------
Dr. Greg Forlenza is an endocrinologist. Dr. Forlenza has an ongoing commercial relationship with Insulet and Insulet has paid him a fee to participate in this podcast. The opinions and views expressed in this podcast are his own.
From the publisher's feed

90,860 Listeners

26,175 Listeners

102 Listeners

1,721 Listeners

217 Listeners

3,341 Listeners

69,491 Listeners

7,935 Listeners

275 Listeners

57,617 Listeners

969 Listeners

19,058 Listeners

49 Listeners

14 Listeners

12,481 Listeners